Cargando…

Effect of Haloperidol and Risperidone on Serum Melatonin and GAP-43 in Patients with Schizophrenia: A Prospective Cohort Study

OBJECTIVE: Serum melatonin, a biomarker of circadian rhythm, can upregulate Growth-associated protein 43 (GAP-43) which is involved in neural regeneration and plasticity. The present study was conducted to investigate the adequacy of the first-line antipsychotic drugs to improve sleep and circadian...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maiti, Rituparna, Mishra, Biswa Ranjan, Jena, Monalisa, Mishra, Archana, Nath, Santanu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean College of Neuropsychopharmacology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7851459/ https://www.ncbi.nlm.nih.gov/pubmed/33508796 http://dx.doi.org/10.9758/cpn.2021.19.1.125

Ejemplares similares

Effect of Repetitive Transcranial Magnetic Stimulation on Seizure Frequency and Epileptiform Discharges in Drug-Resistant Epilepsy: A Meta-Analysis
por: Mishra, Archana, et al.
Publicado: (2020)

Risperidone-Induced Tardive Akathisia: A Rare Antipsychotic Side Effect with Management Issues
por: Mishra, Biswa Ranjan, et al.
Publicado: (2019)

The rare association of rapid eye movement behavior disorder and Fahr's disease: A harbinger for neurodegeneration?
por: Mishra, Biswa Ranjan, et al.
Publicado: (2020)

Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
por: Olfson, Mark, et al.
Publicado: (2007)

Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor in Bipolar Mania: An Exploratory Study
por: Maiti, Rituparna, et al.
Publicado: (2017)

Intractable hiccups (singultus) abolished by risperidone, but not by haloperidol
por: Nishikawa, Tadashi, et al.
Publicado: (2015)

Donepezil for Compulsive Behavior in Degenerative Dementia: Case Series
por: Mishra, Biswa Ranjan, et al.
Publicado: (2018)

The Therapeutic Effectiveness of Risperidone on Negative Symptoms of Schizophrenia in Comparison with Haloperidol: A Randomized Clinical Trial
por: Mirabzadeh, Arash, et al.
Publicado: (2014)

RISPERIDONE VERSUS HALOPERIDOL IN ACUTE AND TRANSIENT PSYCHOTIC DISORDER
por: Chaudhuri, Bijoy Pratim, et al.
Publicado: (2000)

An adolescent crush or delusion of erotomania? Dissecting the normal from the pathological
por: Mishra, Biswa Ranjan, et al.
Publicado: (2019)

COMPARATIVE STUDY OF RISPERIDONE AND HALOPERIDOL ON CLINICAL AND PSYCHOSOCIAL PARAMETERS IN TREATMENT OF SCHIZOPHRENIA : A RANDOMISED OPEN TRIAL
por: Shrivastava, Amresh, et al.
Publicado: (2000)

A double-blind randomized trial between risperidone and haloperidol in drug-naive patients with paranoid schizophrenia
por: Sagar, K.J. Vijay, et al.
Publicado: (2005)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
por: Gao, Keming, et al.
Publicado: (2013)

Successful Management of Patient with Sheehan's Syndrome Presenting with Psychosis and Catatonia
por: Nath, Santanu, et al.
Publicado: (2018)

Euprolactinemic Galactorrhea with Paroxetine: Exploring the Missing Link
por: Mishra, Shree, et al.
Publicado: (2019)

Risperidone Provides Better Improvement of Sleep Disturbances Than Haloperidol Therapy in Schizophrenia Patients With Cannabis-Positive Urinalysis
por: Thomas-Brown, Peta-Gaye L., et al.
Publicado: (2018)

Methamphetamine-Associated Psychosis and Treatment With Haloperidol and Risperidone: A Pilot Study
por: Samiei, Mercede, et al.
Publicado: (2016)

Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study)
por: García-Cabeza, Ignacio, et al.
Publicado: (2001)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Agarwal, A.K., et al.
Publicado: (1998)

Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells
por: Racki, Valentino, et al.
Publicado: (2021)

Comprehensive DNA Methylation Analysis of Human Neuroblastoma Cells Treated With Haloperidol and Risperidone
por: Du, Jianbin, et al.
Publicado: (2021)

RISPERIDONE IN SCHIZOPHRENIA
por: Agashe, Mohan, et al.
Publicado: (1999)

RISPERIDONE IN SCHIZOPHRENIA
por: Kumar, P.N. Suresh
Publicado: (1999)

Symposium Title: Nomophobia (Fear of being without owns smartphone): Emerging realm of gadget addiction
por: Ranjan, Rajeev, et al.
Publicado: (2022)

Effect of add-on alpha lipoic acid on psychopathology in patients with treatment-resistant schizophrenia: a pilot randomized double-blind placebo-controlled trial
por: Mishra, Archana, et al.
Publicado: (2022)

Acute Dystonia Following Opioid Withdrawal: An Uncommon Presentation
por: Nath, Santanu, et al.
Publicado: (2019)

Add-on effect of Brahmi in the management of schizophrenia
por: Sarkar, Sukanto, et al.
Publicado: (2012)

Levothyroxine Therapy and Predictors of Cardiovascular Risk in Clinical Hypothyroidism: A Prospective Cohort Study
por: Maiti, Rituparna, et al.
Publicado: (2022)

RISPERIDONE IN INDIAN PATIENTS WITH SCHIZOPHRENIA
por: Duggal, Harpreet S., et al.
Publicado: (1999)

Pretreatment Serum MCP-1 Level Predicts Response to Risperidone in Schizophrenia
Publicado: (2017)

Correlation of hair risperidone concentration and serum level among patients with schizophrenia
por: Sun, Xiujia, et al.
Publicado: (2019)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

COMPARATIVE EFFICACY OF CENTBUTINDOLE & RISPERIDONE IN SCHIZOPHRENIA
por: Chandra, R., et al.
Publicado: (2002)

Risperidone Associated Paralytic Ileus in Schizophrenia
por: Ramamourthy, Parthasarathy, et al.
Publicado: (2013)

OPEN DRUG TRIAL WITH HALOPERIDOL DECANOATE INJECTIONS IN SCHIZOPHRENIA
por: Varma, V.K., et al.
Publicado: (1989)

A COMPARATIVE EFFICACY STUDY OF CENTBUTINDOLE AND HALOPERIDOL IN SCHIZOPHRENIA
por: Singh, Harjeet, et al.
Publicado: (1999)

Clinical utility of the risperidone formulations in the management of schizophrenia
por: Madaan, Vishal, et al.
Publicado: (2011)

Life-threatening hypoglycemia attributable to haloperidol in a patient with schizophrenia
por: Couto, Joana, et al.
Publicado: (2019)

Essential Medicines: An Indian Perspective
por: Maiti, Rituparna, et al.
Publicado: (2015)

Determination of Chlorpromazine, Haloperidol, Levomepromazine, Olanzapine, Risperidone, and Sulpiride in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS)
por: Khelfi, Abderrezak, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kcq7qpqn04m7fv8tc65hdpf0gj